Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: insulin regimen + insulin regimens + insulin  Related to the article below (Last Update: 5/5/2008)

Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical ...
PR Newswire (press release), NY -
... in SYMLIN(R) (pramlintide acetate) injection, which is indicated for use by patients with type 1 and type 2 diabetes who use mealtime insulin. ...AMLN
Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III ...
Earthtimes, UK - Apr 9, 2008
Type 1, previously known as juvenile diabetes or insulin-dependent diabetes, is a disorder of the body's immune system. In type 1 diabetes, ...
Developments in the Treatment of Colorectal Cancer: A Report from ...
Cancer Consultants, ID - Apr 7, 2008
Dr. Rothenberg?s presentation focused on three candidate proteins and pathways: Insulin-like Growth Factor-I Receptor (IGF-IR), Src, and Toll-Like Receptor ...
ImClone Systems Reports First Quarter 2008 Financial Results
Business Wire (press release), CA - Apr 24, 2008
The initial stage of a series of Phase I/II clinical trials of IMC-A12, its anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, ...IMCL
Source: Google News

… Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin … -
P Vague, JL Selam, S Skeie, I De Leeuw, JWF Elte, … - Diabetes Care, 2003 - Am Diabetes Assoc
... type 1 diabetes on multiple daily insulin regimens: US Insulin ... safety of 6-month
treatment with insulin detemir in ... patients on a basal/bolus regimen (Abstract ...

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, … -
JS Skyler, RS Weinstock, P Raskin, JF Yale, E … - Diabetes Care, 2005 - Am Diabetes Assoc
... Article. Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1
Diabetic Subjects. A 6-month, randomized, comparative trial. ...

… type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen -
JC Cappelleri, WT Cefalu, J Rosenstock, IA … - Clinical Therapeutics, 2002 - Elsevier
... in- haled and subcutaneous insulin regimens. The aim of this article was to explore
and compare treatment satisfaction of an in- haled insulin regimen versus a ...

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic … -
K Malmberg, L Ryden, S Efendic, J Herlitz, P Nicol … - Journal of the American College of Cardiology, 1995 - Am Coll Cardio Found
... Insulin-glucose infusion followed by a multidose insulin regimen improved long-term
prognosis in diabetic patients with acute myocardial infarction. ...

Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus -
WS Queale, AJ Seidler, FL Brancati - Archives of Internal Medicine, 1997 - Am Med Assoc
... scale insulin regimens were associated with a 3-fold higher risk of hyperglycemic
episodes compared with individuals following no pharmacologic regimen (RRs ...

… in Prepubertal Children With Type 1 Diabetes on Standard Insulin Regimen: Use of Continuous Glucose … -
R Amin, K Ross, CL Acerini, JA Edge, J Warner, DB … - Diabetes Care, 2003 - Am Diabetes Assoc
... in prepubertal diabetic children on standard insulin regimens, particularly at night ...
with younger age, increasing insulin dose, insulin regimen, and increased ...

Twice Daily Versus Four Times Daily Insulin Dose Regimens for Diabetes in Pregnancy: Randomised … -
Z Nachum, I Ben-Shlomo, E Weiner, E Shalev - Obstetrical & Gynecological Survey, 2000 - obgynsurvey.com
... and throughout all of pregnancy; glucose monitoring and insulin regimens must be ...
The four-times-daily insulin regimen brings us closer to physiologic insulin ...

… and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen ( … -
R Rabasa-Lhoret, J Bourque, F Ducros, JL Chiasson - Diabetes Care, 2001 - Am Diabetes Assoc
... Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated
Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro). ...

Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes … -
RC Turner, CA Cull, V Frighi, RR Holman - JAMA, 1999 - Am Med Assoc
... 500 mg/d, glyburide 20 mg/d, and metformin 2550 mg/d). The initial insulin regimen
consisted of a once-daily dose of long-acting or isophane insulin. ...

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes -
K Ra?lov?, M Bogoev, I Raz, G Leth, MA Gall, N … - Diabetes Research and Clinical Practice, 2004 - Elsevier
... 1 diabetes using a basal-bolus regimen, Clin. ... gain and the risk of developing insulin
resistance syndrome. ... and their association with treatment regimens in the ...

Source: Google Scholar

Insulin regimens comparable for diabetes control

Last Updated: 2007-12-20 17:06:47 -0400 (Reuters Health)

By Will Boggs, MD

NEW YORK (Reuters Health) - For patients with type 2 diabetes beginning insulin therapy, blood sugar control and quality of life seem to be similar with either flexible intensive insulin therapy (FIT) or conventional insulin therapy (CIT) according to a report in the journal Diabetes Care.

The authors note that CIT is based on fixed insulin dosing and fixed carbohydrate intake, whereas with FIT, the insulin dose is adjusted in accordance with blood sugar levels and desired carbohydrate intake. CIT is easier, but FIT offers more dietary freedom.

"It seems that the potential greater flexibility under FIT is not of major importance for the majority of patients with type 2 diabetes," Dr. Christof Kloos from Friedrich-Schiller-University, Jena, Germany told Reuters Health. "In our study, FIT in type 2 diabetes did not lead to improved treatment satisfaction or quality of life. This contrasts to patients with type 1 diabetes."

Kloos and colleagues investigated whether FIT and CIT provide equivalent outcomes in a study of adults with type 2 diabetes who had never received insulin before.

CIT and FIT were comparable in their ability to lower blood sugar levels and body weight. Moreover, no differences were seen between the regimens in terms of their effects on blood pressure or insulin dosage.

Twenty patients preferred to continue CIT, and 18 patients preferred to continue FIT, the investigators say.

"Due to our results, there is no medical reason to prefer either FIT or CIT," Kloos said.

"In further research projects, our focus will be to single out patients with type 2 diabetes who may profit from greater flexibility," Kloos said.

SOURCE: Diabetes Care, November 2007.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.